from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
Telix Pharmaceuticals Investor Presentation: 56% FY25 revenue growth, pipeline advances
-
How to invest $300 a month in Australian shares to target a $50,000 annual second income
-
These ASX shares look too good to ignore after the recent pullback
-
3 ASX shares below $5 with huge potential